Skip to main content

Juan Manuel Pericàs Pulido

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Juan Manuel Pericàs Pulido

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria Buti Ferret, Montserrat Gomez Perez, Judit Romero Vico, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Daniel Martinez Vazquez, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

StopALD

IP: Meritxell Ventura Cots
Collaborators: Juan Manuel Pericàs Pulido, Sonia Carramiñana Mayor, Juan Bañares Sanchez
Funding agency: Ajuntament Barcelona
Funding: 119700
Reference: AJUNT.BCN/CIENCIA_INNOV/2022/VENTURA
Duration: 08/12/2022 - 07/06/2024

EU Patient- cEntric clinicAl tRial pLatform - EU PEARL.

IP: Joan Genescà Ferrer
Collaborators: Santiago Pérez Hoyos, Anna Sanjuan Viaplana, Xavier Cañas Perea, Juan Espinosa Pereiro, Juan Manuel Pericàs Pulido, José Antonio Ramos Quiroga, Israel Molina Romero, Alex Sánchez Pla, Inmaculada Fuentes Camps, Adrián Sánchez Montalvá, Pol Ibañez Jimenez, Olga Sánchez- Maroto Carrizo, Gara Arteaga Henriquez, EU Patient- cEntric clinicAl tRial pLatform - EU PEARL., Janna Anthonina Slabbekoorn, Albert Barberà LLuis
Funding agency: The Innovative Medicines Initiative
Funding: 1987375
Reference: EU-PEARL_H2020_IMI2-2018
Duration: 01/11/2019 - 30/04/2023

Screening for liver fibrosis - population-based study across European countries

IP: Juan Manuel Pericàs Pulido
Collaborators: Joan Genescà Ferrer, Maria Francesca Cortese, Laura Puente Ramo, Juan Bañares Sanchez
Funding agency: EUROPEAN COMMISSION
Funding: 172385.95
Reference: LIVERSCREEN_H2020SC1BHC2019
Duration: 01/01/2020 - 30/06/2025

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Related professionals

Edoardo Caronna

Edoardo Caronna

Postdoctoral researcher
Headache and Neurological Pain
Read more
Selen Ozkan

Selen Ozkan

Predoctoral researcher
Clinical and Translational Bioinformatics
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Pediatric Neurology
Read more
Tamara Garcia Antolinez

Tamara Garcia Antolinez

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.